von Hundelshausen P - Search Results

1

Bleeding by Bruton Tyrosine Kinase-Inhibitors: Dependency on Drug Type and Disease.

von Hundelshausen P, Siess W. von Hundelshausen P, et al. Cancers (Basel). 2021 Mar 4;13(5):1103. doi: 10.3390/cancers13051103. Cancers (Basel). 2021. PMID: 33806595 Free PMC article. Review.

2

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Goldmann L, Duan R, Kragh T, Wittmann G, Weber C, Lorenz R, von Hundelshausen P, Spannagl M, Siess W. Goldmann L, et al. Among authors: von hundelshausen p. Blood Adv. 2019 Dec 10;3(23):4021-4033. doi: 10.1182/bloodadvances.2019000617. Blood Adv. 2019. PMID: 31809536 Free PMC article.

3

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors.

von Hundelshausen P, Lorenz R, Siess W, Weber C. von Hundelshausen P, et al. Thromb Haemost. 2021 Nov;121(11):1395-1399. doi: 10.1055/a-1481-3039. Epub 2021 May 28. Thromb Haemost. 2021. PMID: 33851389 Review.

4

Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time.

Duan R, Goldmann L, Brandl R, Spannagl M, Weber C, Siess W, von Hundelshausen P. Duan R, et al. Among authors: von hundelshausen p. Front Cardiovasc Med. 2021 Sep 24;8:749022. doi: 10.3389/fcvm.2021.749022. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34631841 Free PMC article.

5

VITT after ChAdOx1 nCoV-19 Vaccination.

Weber C, von Hundelshausen P, Siess W. Weber C, et al. Among authors: von hundelshausen p. N Engl J Med. 2021 Dec 2;385(23):2203-2204. doi: 10.1056/NEJMc2111026. Epub 2021 Nov 3. N Engl J Med. 2021. PMID: 34731556 No abstract available.

6

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton's Tyrosine Kinase.

Duan R, Goldmann L, Li Y, Weber C, Siess W, von Hundelshausen P. Duan R, et al. Among authors: von hundelshausen p. Int J Mol Sci. 2021 Dec 22;23(1):76. doi: 10.3390/ijms23010076. Int J Mol Sci. 2021. PMID: 35008508 Free PMC article.

7

Targeting platelet-derived CXCL12 impedes arterial thrombosis.

Leberzammer J, Agten SM, Blanchet X, Duan R, Ippel H, Megens RTA, Schulz C, Aslani M, Duchene J, Döring Y, Jooss NJ, Zhang P, Brandl R, Stark K, Siess W, Jurk K, Heemskerk JWM, Hackeng TM, Mayo KH, Weber C, von Hundelshausen P. Leberzammer J, et al. Among authors: von hundelshausen p. Blood. 2022 Apr 28;139(17):2691-2705. doi: 10.1182/blood.2020010140. Blood. 2022. PMID: 35313337 Free PMC article.

8

Immune-mediated and lipid-mediated platelet function in atherosclerosis.

Ahmadsei M, Lievens D, Weber C, von Hundelshausen P, Gerdes N. Ahmadsei M, et al. Among authors: von hundelshausen p. Curr Opin Lipidol. 2015 Oct;26(5):438-48. doi: 10.1097/MOL.0000000000000212. Curr Opin Lipidol. 2015. PMID: 26270811 Review.

9

The marriage of chemokines and galectins as functional heterodimers.

von Hundelshausen P, Wichapong K, Gabius HJ, Mayo KH. von Hundelshausen P, et al. Cell Mol Life Sci. 2021 Dec;78(24):8073-8095. doi: 10.1007/s00018-021-04010-6. Epub 2021 Nov 12. Cell Mol Life Sci. 2021. PMID: 34767039 Free PMC article. Review.

10

Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond.

Weber C, Habenicht AJR, von Hundelshausen P. Weber C, et al. Among authors: von hundelshausen p. Eur Heart J. 2023 Aug 1;44(29):2672-2681. doi: 10.1093/eurheartj/ehad304. Eur Heart J. 2023. PMID: 37210082 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters